Compound Detail
CHEMBL258805
SU-9516 Phase I
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Phase I
Basic Information
| ChEMBL ID | CHEMBL258805 |
| Name | SU-9516 |
| Phase | Phase I |
| Structure Type | MOL |
| InChI Key | QNUKRWAIZMBVCU-WCIBSUBMSA-N |
24
Targets
48
Activities
2
Assay Types
0
PK Parameters
20
Publications
2
Known Names
1
Mechanisms
Molecular Properties
241.2
MW (Da)
1.91
ALogP
3
HBA
2
HBD
67.0
PSA (Ų)
0.79
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Cyclin-dependent kinase 2 inhibitor | INHIBITOR | Cyclin-dependent kinase 2 | ✓ | ✓ |
Activity Summary
IC50 43 meas. best 7.66
EC50 5 meas. best 6.75
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Cyclin-dependent kinase 5/CDK5 activator 1 CHEMBL1907600 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 7.66 | 6.1667 | 22.0 | 9 |
| Cyclin-dependent kinase 2 CHEMBL301 | IC50 | 7.66 | 6.728 | 22.0 | 5 |
| Cyclin-dependent kinase 1/cyclin B CHEMBL2094127 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| Cyclin-dependent kinase 2/cyclin E1 CHEMBL1907605 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
| CDK2/Cyclin A2 CHEMBL3038469 | IC50 | 7.57 | 7.57 | 27.0 | 1 |
| Cyclin-dependent kinase 1 CHEMBL308 | IC50 | 7.4 | 7.33 | 40.0 | 2 |
| Cyclin-dependent kinase 5 CHEMBL4036 | IC50 | 7.19 | 7.19 | 65.0 | 1 |
| Vascular endothelial growth factor receptor 2 CHEMBL279 | IC50 | 6.89 | 6.89 | 130.0 | 1 |
| Cyclin-dependent kinase 1/cyclin B1 CHEMBL1907602 | IC50 | 6.78 | 6.78 | 168.0 | 1 |
| Trypanosoma brucei CHEMBL612849 | EC50 | 6.75 | 6.75 | 180.0 | 1 |
| Cyclin-dependent kinase 4 CHEMBL331 | IC50 | 6.7 | 6.61 | 200.0 | 2 |
| Serine/threonine-protein kinase tousled-like 2 CHEMBL5404 | IC50 | 6.62 | 6.4733 | 240.0 | 3 |
| Glycogen synthase kinase-3 CHEMBL2095188 | IC50 | 6.46 | 6.46 | 350.0 | 1 |
| CDK7/Cyclin H/MNAT1 CHEMBL3038473 | IC50 | 6.04 | 6.04 | 905.0 | 1 |
| Unchecked CHEMBL612545 | EC50 | 6.02 | 5.91 | 956.0 | 2 |
| ATP-dependent molecular chaperone HSP82 CHEMBL1293251 | EC50 | 5.9 | 5.9 | 1250.0 | 1 |
| CDK9/cyclin T1 CHEMBL2111389 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
| Proto-oncogene tyrosine-protein kinase receptor Ret CHEMBL2041 | IC50 | 5.8 | 5.8 | 1600.0 | 1 |
| Cyclin-dependent kinase 4/cyclin D1 CHEMBL1907601 | IC50 | 5.77 | 5.77 | 1700.0 | 1 |
| Interferon-induced, double-stranded RNA-activated protein kinase CHEMBL5785 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| Spiral organ of cochlea CHEMBL4296537 | EC50 | 5.22 | 5.22 | 6000.0 | 1 |
| Plasmodium falciparum CHEMBL364 | IC50 | 5.2 | 5.0143 | 6309.6 | 7 |
| Proto-oncogene tyrosine-protein kinase Src CHEMBL267 | IC50 | 4.96 | 4.96 | 11000.0 | 1 |
| Platelet-derived growth factor receptor beta CHEMBL1913 | IC50 | 4.75 | 4.75 | 18000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19734910 | 10.1038/nchembio.215 | Plasmodium falciparum | 7 |
| 18077363 | 10.1073/pnas.0708800104 | Unchecked | 5 |
| 36701569 | 10.1021/acs.jmedchem.2c01731 | Cyclin-dependent kinase 2 | 4 |
| 38636130 | 10.1016/j.ejmech.2024.116357 | Serine/threonine-protein kinase tousled-like 2 | 4 |
| 23398362 | 10.1042/bj20121418 | cGMP-dependent protein kinase 1 | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase Lck | 4 |
| 23398362 | 10.1042/bj20121418 | Tyrosine-protein kinase HCK | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin receptor | 4 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 23398362 | 10.1042/bj20121418 | Protein kinase C beta type | 4 |
| 23398362 | 10.1042/bj20121418 | Insulin-like growth factor 1 receptor | 4 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase mTOR | 4 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 5/CDK5 activator 1 | 4 |
| 30234987 | 10.1021/acs.jmedchem.8b00049 | HCT-116 | 3 |
| 23398362 | 10.1042/bj20121418 | Mitogen-activated protein kinase 10 | 2 |
| 23398362 | 10.1042/bj20121418 | Inhibitor of nuclear factor kappa-B kinase subunit alpha | 2 |
| 23398362 | 10.1042/bj20121418 | Aurora kinase A | 2 |
| 23398362 | 10.1042/bj20121418 | Serine/threonine-protein kinase 4 | 2 |
| 23398362 | 10.1042/bj20121418 | Cyclin-dependent kinase 2/cyclin E | 2 |
| 23398362 | 10.1042/bj20121418 | Dual specificity mitogen-activated protein kinase kinase 1 | 2 |
Data from ChEMBL 36 via Core Engine